Janet Valdez

3.7k total citations · 1 hit paper
42 papers, 1.7k citations indexed

About

Janet Valdez is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Janet Valdez has authored 42 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Genetics, 20 papers in Pathology and Forensic Medicine and 19 papers in Hematology. Recurrent topics in Janet Valdez's work include Chronic Lymphocytic Leukemia Research (28 papers), Lymphoma Diagnosis and Treatment (20 papers) and Immunodeficiency and Autoimmune Disorders (12 papers). Janet Valdez is often cited by papers focused on Chronic Lymphocytic Leukemia Research (28 papers), Lymphoma Diagnosis and Treatment (20 papers) and Immunodeficiency and Autoimmune Disorders (12 papers). Janet Valdez collaborates with scholars based in United States, Brazil and Ireland. Janet Valdez's co-authors include Adrian Wiestner, Mohammed Farooqui, Xin Tian, Susan Soto, Maryalice Stetler‐Stevenson, Jennifer Lotter, Katherine R. Calvo, Sarah E. M. Herman, Constance M. Yuan and Gerald E. Marti and has published in prestigious journals such as New England Journal of Medicine, Blood and The Journal of Immunology.

In The Last Decade

Janet Valdez

39 papers receiving 1.7k citations

Hit Papers

Eltrombopag Added to Standard Immunosuppression for Aplas... 2017 2026 2020 2023 2017 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia
    2017 337 citations Danielle M. Townsley, Phillip Scheinberg et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Janet Valdez United States 17 1.1k 758 746 608 308 42 1.7k
Louis Terriou France 20 567 0.5× 242 0.3× 807 1.1× 790 1.3× 177 0.6× 112 1.8k
Ana Balanzategui Spain 25 492 0.5× 539 0.7× 491 0.7× 427 0.7× 459 1.5× 70 1.5k
David Hakimian United States 17 657 0.6× 446 0.6× 295 0.4× 306 0.5× 274 0.9× 48 1.1k
Paula Cramer Germany 20 1.2k 1.1× 1.1k 1.4× 335 0.4× 445 0.7× 273 0.9× 74 1.5k
Jamile M. Shammo United States 17 587 0.5× 227 0.3× 874 1.2× 296 0.5× 305 1.0× 79 1.5k
Parameswaran Venugopal United States 21 482 0.4× 339 0.4× 1.1k 1.4× 330 0.5× 412 1.3× 130 1.9k
M.J. Mackie United Kingdom 16 639 0.6× 447 0.6× 372 0.5× 335 0.6× 182 0.6× 39 1.1k
Francesc Cobo Spain 18 650 0.6× 573 0.8× 352 0.5× 176 0.3× 367 1.2× 38 1.2k
Ho‐Jin Shin South Korea 22 365 0.3× 691 0.9× 944 1.3× 412 0.7× 655 2.1× 182 2.0k
Rajko Kušec Croatia 24 887 0.8× 341 0.4× 1.0k 1.4× 219 0.4× 280 0.9× 104 2.0k

Countries citing papers authored by Janet Valdez

Since Specialization
Citations

This map shows the geographic impact of Janet Valdez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janet Valdez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janet Valdez more than expected).

Fields of papers citing papers by Janet Valdez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janet Valdez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janet Valdez. The network helps show where Janet Valdez may publish in the future.

Co-authorship network of co-authors of Janet Valdez

This figure shows the co-authorship network connecting the top 25 collaborators of Janet Valdez. A scholar is included among the top collaborators of Janet Valdez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janet Valdez. Janet Valdez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Norberg, Scott M., Janet Valdez, Stacey L. Doran, et al.. (2025). PRGN-2012 gene therapy in adults with recurrent respiratory papillomatosis: a pivotal phase 1/2 clinical trial. The Lancet Respiratory Medicine. 13(4). 318–326. 6 indexed citations
3.
Fan, Xing, Ronan Desmond, Thomas Winkler, et al.. (2020). Eltrombopag for patients with moderate aplastic anemia or uni-lineage cytopenias. Blood Advances. 4(8). 1700–1710. 32 indexed citations
4.
Çelik, Haydar, Katherine E. Lindblad, Bogdan Popescu, et al.. (2020). Highly multiplexed proteomic assessment of human bone marrow in acute myeloid leukemia. Blood Advances. 4(2). 367–379. 38 indexed citations
5.
6.
Çelik, Haydar, Katherine E. Lindblad, Bogdan Popescu, et al.. (2019). A Novel Proteomic Profiling of the Bone Marrow Microenvironment Reveals Elevated Levels of the Chemokine CCL23 Isoforms in Acute Myeloid Leukemia. Blood. 134(Supplement_1). 2709–2709.
7.
Aue, Georg, Clare Sun, Delong Liu, et al.. (2018). Activation of Th1 Immunity within the Tumor Microenvironment Is Associated with Clinical Response to Lenalidomide in Chronic Lymphocytic Leukemia. The Journal of Immunology. 201(7). 1967–1974. 21 indexed citations
8.
Townsley, Danielle M., Phillip Scheinberg, Thomas Winkler, et al.. (2017). Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia. New England Journal of Medicine. 376(16). 1540–1550. 337 indexed citations breakdown →
9.
Herndon, Thomas M., Nakhle S. Saba, Janet Valdez, et al.. (2017). Direct in vivo evidence for increased proliferation of CLL cells in lymph nodes compared to bone marrow and peripheral blood. Leukemia. 31(6). 1340–1347. 88 indexed citations
10.
Olnes, Matthew J., Yuri Kotliarov, Angélique Biancotto, et al.. (2016). Effects of Systemically Administered Hydrocortisone on the Human Immunome. Scientific Reports. 6(1). 23002–23002. 122 indexed citations
11.
Townsley, Danielle M., James N. Cooper, Thomas Winkler, et al.. (2016). Myeloid Neoplasm Gene Somatic Mutations in Patients with Severe Aplastic Anemia Treated with Eltrombopag and Standard Immunosuppression. Blood. 128(22). 727–727. 1 indexed citations
12.
Niemann, Carsten Utoft, Sarah E. M. Herman, Irina Marić, et al.. (2015). Disruption of in vivo Chronic Lymphocytic Leukemia Tumor–Microenvironment Interactions by Ibrutinib – Findings from an Investigator-Initiated Phase II Study. Clinical Cancer Research. 22(7). 1572–1582. 160 indexed citations
13.
Skarzynski, Martin, Carsten Utoft Niemann, Yuh Shan Lee, et al.. (2015). Interactions between Ibrutinib and Anti-CD20 Antibodies: Competing Effects on the Outcome of Combination Therapy. Clinical Cancer Research. 22(1). 86–95. 62 indexed citations
14.
Farooqui, Mohammed, Janet Valdez, Susan Soto, et al.. (2015). Single Agent Ibrutinib in CLL/SLL Patients with and without Deletion 17p. Blood. 126(23). 2937–2937. 7 indexed citations
15.
Desmond, Ronan, Barbara Weinstein, Aparna Parikh, et al.. (2015). 56 ELTROMBOPAG FOR LOW TO INTERMEDIATE-2 RISK MYELODYSPLASTIC SYNDROME. Leukemia Research. 39. S26–S27. 3 indexed citations
16.
Farooqui, Mohammed, Janet Valdez, Susan Soto, et al.. (2015). Atrial Fibrillation in CLL/SLL Patients on Ibrutinib. Blood. 126(23). 2933–2933. 33 indexed citations
17.
18.
19.
Aue, Georg, Susan Soto, Janet Valdez, et al.. (2009). A Phase II Trial of Pulse Dosing Lenalidomide: 3 Weeks On 3 Weeks off in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.. Blood. 114(22). 3427–3427. 2 indexed citations
20.
Valdez, Janet, et al.. (1976). [3 cases of bleeding gastric leiomyoma].. PubMed. 48(5). 625–38. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Louis Terriou Breakdown of academic impact, for papers by Ana Balanzategui Breakdown of academic impact, for papers by David Hakimian Breakdown of academic impact, for papers by Paula Cramer Breakdown of academic impact, for papers by Jamile M. Shammo Breakdown of academic impact, for papers by Parameswaran Venugopal Breakdown of academic impact, for papers by M.J. Mackie Breakdown of academic impact, for papers by Francesc Cobo Breakdown of academic impact, for papers by Ho‐Jin Shin Breakdown of academic impact, for papers by Rajko Kušec
Rankless by CCL
2026